COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

202306_BB_Drug Shortages_pt2.png

Read more about how Canada and the U.S. regulators approach drug shortages, including duplicating approved drugs and the impacts of last winter’s drug shortages.

202306_BB_Drug Shortages_pt1.png

North America’s two largest countries, Canada and the U.S., have very different approaches to drug shortages. Read Part 1 of our two-part series to learn more about the distinctions between Health Canada and FDA regulations.

202303_BB_Arthritis-Prep for Pain and Joint Health_823x462.png

As we wind down National Arthritis Awareness Month, learn how compounders may help patients with the most common type of arthritis using compounded preparations and nutritional supplements.

b1d19947-cf44-402f-843b-591842895a39.jpg

This Profile in Personalized Medicine highlights Stacy Hightower. She is the lead marketer and compounding compliance officer for Las Colinas Pharmacy in Irving, Texas, owned by Jim and Jan Hrncir. They have been a proud PCCA member since 1990. Our new 2023 profiles ask pharmacy compounders how they incorporate PCCA’s Principles into their pharmacies.

202305_BB_Nutritional and Lifestyle Support for PCOS.png

Polycystic ovary syndrome (PCOS) is the most prevalent hormonal disorder affecting women of reproductive age across the globe and the CDC estimates PCOS may be one of the most common causes of infertility. Learn how to help patients with PCOS.

202305_BB_GSM Common Sympton of Menopause.png

Genitourinary syndrome of menopause (GSM), also known as vulvovaginal atrophy, is common among menopausal women. Learn more about GSM, relevant hormones and the importance of choosing the right base for compounding preparations.

202304_Blog Banner_Methylation, Methylcobalamin and ASD.png

Scientists detected evidence of DNA methylation abnormalities in patients with autism spectrum disorder (ASD). Learn how compounders may potentially help ASD patients with methylcobalamin preparations.

202304_Blog_Methylene_1768x923.jpg

Learn why methylene blue, synthesized in 1876 as a dye for the textile industry, has rekindled interest for therapeutic use in diseases.

202304_The Power of Yet_1768x923_.jpg

Read why Kayla Valigura, PharmD candidate and 2022 PCCA Institute Scholarship award winner, wants your help in acting on something near and dear to her heart.

How_to_Determine_API_Calculations_in_Pharmacy_Compounding.jpg

PCCA's Matt Martin and Melissa Merrell Rhoads provide guidance and examples to help you determine API calculations in your compounding pharmacy.